August 17, 2026

#352: Chris Kiple, CEO of Solius Labs

Listen On:
Image of Chris Kiple, with text
Presented by
EGYM logo

Today, I’m joined by Chris Kiple, CEO of Solius Labs.

A decade in development, Solius’s FDA-cleared UVB light therapy device personalizes dosage by skin type, aiming to replicate the benefits of sunlight while minimizing carcinogenic risk.

In this episode, we discuss sunlight as a foundational pillar of health and longevity.

We also cover:

  • Why sun avoidance is deadlier than smoking
  • Designing a skin scanner for personalized UVB dosing
  • Moving UVB therapy from clinical dermatology to consumer health

The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com  to learn more about its smart fitness ecosystem for fitness and health facilities.


Chapters:
(00:00) Introduction
(00:29) Swedish longevity study
(01:20) Chris background and Solius overview
(02:05) UVB light therapy foundation
(04:00) 10-year development and timing
(05:07) Sun exposure evolution and skin type
(08:10) Solius technology and personalized dosing
(09:35) Skin scanning and dosing mechanism
(11:00) FDA clearance and safety focus
(12:40) OTC vs. prescription positioning
(14:15) Safety risk contextualization
(15:42) Healthcare partnerships strategy
(17:50) Dermatology focus
(19:00) Orthopedic and cardiovascular applications
(20:32) Longevity clinic partnerships
(22:35) Swedish and UK biobank studies
(26:00) Hormone production benefits
(27:20) Cardiovascular and nitric oxide improvements
(28:30) Microbiome diversity impact
(31:15) Platform evolution and future devices
(33:20) Team-building and advisory board
(34:45) Listening to early users
(36:40) Where to find
(38:07) Conclusion

Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.